HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Rong-zhen Xu Selected Research

Azurin

1/2005[Cytotoxicity and apoptosis of human osteosarcoma U2OS cells induced by recombinant soluble AZURIN].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Rong-zhen Xu Research Topics

Disease

8Leukemia
11/2012 - 03/2003
4BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
11/2012 - 07/2005
4Neoplasms (Cancer)
11/2012 - 01/2003
2Systemic Lupus Erythematosus (Libman-Sacks Disease)
06/2005 - 01/2005
1Body Weight (Weight, Body)
12/2011
1Body Weight Changes
12/2011
1Necrosis
12/2011
1Acute Promyelocytic Leukemia
05/2007
1Hepatocellular Carcinoma (Hepatoma)
04/2007
1Osteosarcoma (Osteogenic Sarcoma)
01/2005
1Type 2 Diabetes Mellitus (MODY)
08/2003

Drug/Important Bio-Agent (IBA)

6berbamine (penduline)IBA
07/2011 - 09/2004
4Proteins (Proteins, Gene)FDA Link
08/2006 - 09/2004
3Caspase 3 (Caspase-3)IBA
12/2011 - 11/2003
2Messenger RNA (mRNA)IBA
11/2012 - 09/2004
2Imatinib Mesylate (Gleevec)FDA Link
11/2012 - 12/2011
2Ribosomal Proteins (Ribosomal Protein)IBA
03/2003 - 01/2003
1SaltsIBA
11/2012
1tetrandrineIBA
11/2012
1CateninsIBA
11/2012
1Citric Acid (Citrate)FDA LinkGeneric
11/2012
1Caspase 9IBA
12/2011
1Tretinoin (Retinoic Acid)FDA LinkGeneric
05/2007
1Arsenic Trioxide (Trisenox)FDA Link
05/2007
1SurvivinIBA
05/2007
1CaspasesIBA
04/2007
1Non-Receptor Type 11 Protein Tyrosine PhosphataseIBA
07/2005
1Actins (F Actin)IBA
07/2005
1DNA (Deoxyribonucleic Acid)IBA
01/2005
1RNA (Ribonucleic Acid)IBA
01/2005
1AzurinIBA
01/2005
1baicaleinIBA
11/2003
1Retroelements (Retrotransposon)IBA
08/2003
1Biomarkers (Surrogate Marker)IBA
08/2003
1Antineoplastic Agents (Antineoplastics)IBA
03/2003
1NADH DehydrogenaseIBA
01/2003

Therapy/Procedure

1Oral Administration
11/2012
1Aftercare (After-Treatment)
12/2011